Back to UBS Group AG UBS Group AG

SPROSPRO
Showing 8 of 29 quarters

Position history for UBS Group AGUBS Group AG's holdings in SPERO THERAPEUTICS INC

UBS Group AG holds 139,680 shares of SPRO (SPERO THERAPEUTICS INC), worth $308,693 as of 2026-Q2. The position was increased (+4542.1% shares).

Current Value

$308,693

Current Shares

139,680

Total Value Change

+$285,204

Total Shares Change

+122,151

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
139,680
+4542.1%
$308,6930.0%$2.21
26
2026-Q1
Decreased
3,009
-97.4%
$7,0410.0%$2.34
0
2025-Q4
Increased
116,447
+329.7%
$271,3220.0%$2.33
26
2025-Q3
Increased
27,101
+230.7%
$50,9500.0%$1.88
23
2025-Q2
Increased
8,194
+189.9%
$23,7630.0%$2.90
21
2025-Q1
Increased
2,826
+1904.3%
$2,0350.0%$0.72
12
2024-Q4
Decreased
141
-99.2%
$1450.0%$1.03
0
2024-Q3
Increased
17,529
+5195.8%
$23,4890.0%$1.34
21

Other major holders of SPRO: BNP PARIBAS FINANCIAL MARKETS, STATE STREET CORP, Alphabet Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used